StockData
Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc. (SGMT) stock

SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$9.85−0.28 (-2.76%)

Close on Nov 17, 2026Market cap $612.26MP/E –Yield –

Sagimet Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Sagimet Biosciences's price to book ratio was 1.7× on Nov 11, 2026, against 2.0× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×+0.1
2025Dec 31, 20251.6×–

More Sagimet Biosciences figures

See a number that looks wrong?